All posts by medical

mLOY: The genetic defect that explains why men have shorter lives than women – EL PAS USA

We have long been baffled as to why men live around five years less than women, on average. But now a new study suggests that, beyond the age of 60, the main culprit is a genetic defect: the loss of the Y chromosome, which determines sex at birth.

Its clear that men are more fragile, the question is why, explains Lars Forsberg, a researcher at Uppsala University in Sweden.

For decades it was thought that the male Y chromosomes only function was to generate sperm that determine the sex of a newborn. A boy carries one X chromosome from the mother and one Y from the father, while a girl carries two Xs, one from each parent.

In 1963, a team of scientists discovered that as men age, their blood cells lose the Y chromosome due to a copying error that happens when the mother cell divides to produce a daughter cell. In 2014, Forsberg analyzed the life expectancy of older men based on whether their blood cells had lost the Y chromosome, a mutation called mLOY. The effect recorded was mindblowing, the researcher recalls.

Men with fewer Y chromosomes had a higher risk of cancer and lived five and a half years less than those who retained this part of the genome. Three years later, Forsberg discovered that this mutation makes getting Alzheimers three times as likely. What is most worrying is the enormous prevalence of this defect. Twenty percent of men over the age of 60 have the mutation. The rate rises to 40% in those over 70 and 57% in those over 90, according to Forsbergs previous studies. It is undoubtedly the most common mutation in humans, he says.

Until now, nobody knew whether the gradual disappearance of the Y chromosome in the blood played a pivotal role in diseases associated with aging. In a study just published in the journal Science, Forsberg and scientists from Japan and the US demonstrate for the first time that this mutation increases the risk of heart problems, immune system failure and premature death.

The researchers have created the first animal model without a Y chromosome in their blood stem cells: namely, mice modified with the gene-editing tool CRISPR. The study showed that these rodents develop scarring of the heart in the form of fibrosis, one of the most common cardiovascular ailments in humans, and die earlier than normal mice. The authors then analyzed the life expectancy recorded in nearly 15,700 patients with cardiovascular disease whose data are stored in the UK public biobank. The analysis shows that loss of the Y chromosome in the blood is associated with a 30% increased risk of dying from cardiovascular disease.

This genetic factor can explain more than 75% of the difference in life expectancy between men and women over the age of 60, explains biochemist Kenneth Walsh, a researcher at the University of Virginia in the US and co-author of the study. In other words, this mutation would explain four of the five years lower life expectancy in men. Walshs estimate links to a previous study in which men with a high mLOY load live about four years less than those without it.

It is well known that men die earlier than women because they smoke and drink more and are more prone to recklessness. But, beyond the age of 60, genetics becomes the main culprit in the deterioration of their health: It seems as if men age earlier than women, Walsh points out.

The study reveals the molecular keys to the damage associated with the mLOY mutation. Within the large group of blood cells can be found the immune systems white blood cells responsible for defending the body against viruses and other pathogens. The loss of the Y chromosome triggers aberrant behavior in macrophages, a type of white blood cell, causing them to scar heart tissue, which in turn increases the risk of heart failure. Researchers have shown that the damage can be reversed if they give mice pirfenidone, a drug approved to treat humans with idiopathic pulmonary fibrosis, a condition in which the lungs become scarred and breathing becomes increasingly difficult.

There are three factors that increase the risk of Y chromosome loss. The first is the inevitable ageing process. The longer one lives, the more cell divisions occur in the body and the greater the likelihood of mutations occurring in the genome copying process. The second is smoking. Smoking causes you to lose the Y chromosome in your blood at an accelerated rate; if you stop smoking, healthy cells once again become the majority, says Walsh. But the third is also inevitable: other inherited genetic mutations can increase the gradual loss of the Y chromosome in the blood by a factor of five, explains Forsberg.

Both Forsberg and Walsh believe that this study opens up an enormous field of research. Still to be studied is whether men with this mutation also have cardiac fibrosis and whether this is behind their heart attacks and other cardiac ailments. We also need to better understand why losing the Y chromosome damages health. For now, we have shown that the Y chromosome is not just there for reproduction, but is is also important for our health, says Forsberg. The next step is to identify which genes are responsible for the phenomenon.

The loss of this chromosome has been detected in all organs and tissues of the body and at all ages, although it is more evident after 60. It is abundant in the blood because this is a tissue that produces millions of new cells every day from blood stem cells. Healthy stem cells produce healthy daughter cells and mutated ones produce daughter cells with mLOY.

A previous study showed that this mutation of the Y chromosome disrupts the function of up to 500 genes located elsewhere in the genome. It has also been shown to damage lymphocytes and natural killer cells, evident in men with prostate cancer and Alzheimers disease, respectively.

There are hardly any tests for mLOY at present. But Forsberg and his colleagues have designed a PCR test that measures the level of this mutation in the blood and could serve to determine which levels of this mutation are harmful to health. Right now, we see people in their 80s with 80% of their blood cells mutated, but we dont know what impact this has on their health, says Walsh.

Another unanswered question is why men lose the genetic mark of the male with age. The evolutionary logic, argue the authors of the paper, is that men are biologically designed to have offspring as soon as possible and to live 40 to 50 years at most. The spectacular increase in life expectancy in the last century has meant that men and women live to an advanced age 80 and 86 years in Spain, respectively which makes the effect of these mutations more evident. Another fact which possibly has some bearing on the issue: the vast majority of people who reach 100 are women.

To transform all these discoveries into treatments, we first need to better understand this phenomenon, says Forsberg. We men are not designed to live forever, but perhaps we can increase our life expectancy by a few more years.

Biochemist Jos Javier Fuster, who studies pathological mutations in blood cells at the National Center for Cardiovascular Research, stresses the importance of the work. Until now it was not clear whether the loss of Y was the cause of cancer, Alzheimers disease and heart failure, he explains. This is the first demonstration in animals that it has a causal role. The human Y chromosome is different from the mouse chromosome, so the priority now is to accumulate more data in humans. This is a great first step in understanding this new mechanism behind aging-linked diseases, he adds.

The cells of the human body group their DNA into 23 pairs of chromosomes that pair up one by one when a cell copies its genome to generate a daughter cell. The Y is the only one that does not have a symmetrical partner to pair up with: instead, it does so with an X chromosome; and the entire Y chromosome is often lost, explains Luis Alberto Prez Jurado from Pompeu Fabra University in Barcelona. For now, six genes have been identified within the Y chromosome that would be responsible for an impact on health, he says. All of them are related to the proper functioning of the immune system. In part, this would also explain the greater vulnerability of males to viral infections, including Covid-19.

Read the rest here:
mLOY: The genetic defect that explains why men have shorter lives than women - EL PAS USA

CUHK Business School Research Reveals the Genetic Makeup of a Leader – NewsPatrolling

HONG KONG SAR Media OutReach 21 July 2022 Is there such a thing as a natural-born leader? A new study sheds light on the genetic influences on leadership and found a surprising connection with bipolar disorder and alcohol consumption.

Individuals in leadership positions are more likely to have certain genes and not all of them are good. An increased tendency to drink alcohol which has been shown to cause cancer and an increased risk of bipolar disorder are among the negative health indicators associated with leaders, according to findings from a new study.Identifying these specific genes helps us understand how our biology influences occupational health and well-being, and specifically, how that plays out among people in leadership positions.Our findings provide insights into the heredity of leadership positions and also the shared genetic underpinnings between the leadership position itself and ones general health, saysLi Wendong, Associate Professor at Department of Management at The Chinese University of Hong Kong (CUHK) Business School, and a co-author of the study.Our research continues the biological story of leadership. Since the late 1980s, studies using twins have shown that differences in peoples genetic make-up account for 30 percent of differences in whether they hold leadership roles. Now we have gone a step further in and conducted genomic studies using a vast database to identify genes related to leadership, adds Prof Li, who notes that the study has implications for leaders and prospective leaders in managing their health and well-being for their long-term career development.A significant reason why our findings matter is that leaders well-being affects their behaviours, which may influence the performance and well-being of their subordinates, teams, and organisations. The implications arising from a leaders health can be vast, he says.Diving Deeper Beyond Twin StudiesThe research team, which were led by of Prof. Li, Prof. Song Zhaoli at the National University of Singapore and Prof. Fan Qiao at Duke-NUS Medical School, conducted the study using data from the U.K. Biobank, the largest public genetic and health database in the world. Researchers extracted genetic and occupational information of over 240,000 individuals of European ancestry. They also tapped on the U.K. Standard Occupation Classification and U.S. Occupational Information Network for information related to leadership roles and managing demands.Leadership has been an important and classic topic in genetic research since the early 19th century, when modern human genetics was first formed as a scientific field.Modern genetics research on leadership appeared much later using the classic twin approach. Twin studies are studies conducted on identical or fraternal twins. They aim to reveal the relative importance of environmental and genetic influences. Twin research is considered a key tool in behavioural genetics and in content fields, from biology to psychology.The new study, titledGenetics, leadership position, and well-being: An Investigation with a large-scale GWAS, furthered previous areas of inquiry by providing results from a whole-genome exploration of leadership. It unraveled genetic correlations between leadership and known measures of well-being and health. The study also considered other socioeconomic measures such as income and education so that what was revealed was a truer picture of leaders genetic profiles.Watch Out at the TopThe study brought to light possible unique genetic associations between well-being and leadership. It found that genetic influences associated with leadership position may be detrimental to well-being. This is in contrast to previous research that showed a positive correlation between leadership and general health and well-being indicators and revealed a fundamental reason why holding a leadership position is not always beneficial to ones health and well-being.After adjusting for the effects of income and education, holding leadership positions was genetically linked to a higher Body Mass Index, an increased risk for cardiovascular disease, and further reduced longevity.The high psychological demands embedded in holding leadership positions chronic stressors might play a role because they stimulate psycho-biological stress responses, including changes in fat metabolism and cardiovascular function, which are detrimental to health in the long run. says Prof. Li.In other words, leaders may be genetically pre-disposed to develop the above stress-induced diseases and conditions, but the stress involved in being a leader can trigger or exacerbate such an impact.One of the most relevant and surprising genetic markers this study found to be associated with leadership is the genetic variant linked to an increased risk of bipolar disorder and schizophrenia.While those with bipolar disorder or schizophrenia may have some advantages to become leaders, we are the first to find genetic variants linked to both leadership and bipolar disorder and schizophrenia, says Prof. Li.Bipolar disorder, formerly called manic depression, is a mental health condition that can cause mood swings of various severity, ranging from emotional highs (mania or hypomania) and lows (depression). While most people diagnosed with bipolar disorder will experience some emotional symptoms between episodes, some may not experience any.Prior research on bipolar disorder concludes that it is a mixed blessing in leaders. On the one hand, leadership studies found bipolar disorder to be linked to positive traits of high intelligence, creativity, and entrepreneurship. Other research shows it can negatively affect ones job performance.Also observed in the study is a genetic connection between leadership and an increase in alcohol consumption an unhealthy behaviour that has been shown to cause cancer.Personal Traits CountAside from strictly genetic considerations, the research team tested genetic correlations between leadership position and a set of observable personal traits that are traditionally related to leadership: intelligence, risk tolerance, and height. The results suggested that the genes that are believed to drive leadership may also be related to these traits. In finding links between the traits and underlying genes in leaders, researchers think it is possible that these genes may carry genetic influences on leadership through many of these personal traits.While genetic research into the role of leadership is in its infancy, the new study is an important step forward and is likely to shed light on the direction and scope of future studies in the field. While certain genes can play a role in whether an individual turns out to be a leader or not, they may not end up expressing themselves. At the very least, they are not a determining factor in shaping the well-being of a leader. Behaviour and lifestyle can influence the expression of genes and improve the chances of good health in leaders. And good health is always an important asset to any organisation, no matter where leadership resides, Prof. Li adds.Reference:Zhaoli Song, Wen-Dong Li, Xuye Jin, Junbiao Ying, Xin Zhang, Ying Song, Hengtong Li, and Qiao Fan,Genetics, leadership position, and well-being: An investigation with a large-scale GWAS (March 14, 2022). Available athttps://doi.org/10.1073/pnas.2114271119.This article was first published in the China Business Knowledge (CBK) website by CUHK Business School:https://bit.ly/3PsquqYHashtag: #CUHKBusinessSchool

The issuer is solely responsible for the content of this announcement.

Read the original:
CUHK Business School Research Reveals the Genetic Makeup of a Leader - NewsPatrolling

Global Immunoassay Market Strategies, Trends, Forecasts 2022-2027: The Genetic Blizzard and the Move to Point of Care Drive Dramatic Change for…

DUBLIN, July 22, 2022 /PRNewswire/ -- The "Immunoassay Market: Strategies and Trends, Forecasts by Application, Technology, Product, User and by Country, with Multiplex and Point of Care Market Analysis, Executive Guides, Customized Forecasting and Analysis" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up.

Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics.

The report profiles 58 companies, large and small, working in this area. This research makes you the expert in your organization.

Key Topics Covered:

1 Market Guides1.1 Immunoassay Market - Strategic Situation Analysis & COVID Impact1.2 Guide for Executives, Marketing, Sales and Business Development Staff1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition2.1 Immunoassay Markets Definition In This Report2.1.1 Enzyme Based2.1.2 Immunofluorescence2.1.3 Chemiluminescence2.1.4 DNA/NAT2.1.5 RIA & Other2.1.6 Reagents/Kits, Analyzers, Software & Services2.1.7 Infectious Disease2.1.8 Auto-Immune2.1.9 Endocrinology2.1.10 Oncology2.1.11 Cardiology2.1.12 Other Specialty2.2 Market Definition2.2.1 Market Sizes2.2.2 Currency2.2.3 Years2.3 Methodology2.3.1 Authors2.3.2 Sources2.4 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic2.4.1 Global Healthcare Spending2.4.2 Spending on Diagnostics2.4.3 Important Role of Insurance for Diagnostics

3 Industry Overview3.1 Industry Participants3.1.1 IVD Supplier3.1.2 Independent lab specialized/esoteric3.1.3 Independent lab national/regional3.1.4 Independent lab analytical3.1.5 Public National/regional lab3.1.6 Hospital lab3.1.7 Physician lab3.1.8 Audit body3.2 The Clinical Laboratory Market Segments3.2.1 Traditional Market Segmentation3.2.2 Laboratory Focus and Segmentation3.2.3 Hospital Testing Share3.2.4 Economies of Scale3.2.5 Hospital vs. Central Lab3.2.6 Physician Office Lab's3.2.7 Physician's and POCT3.3 Immunoassay -Markets and Discussion3.3.1 Instruments - Genetics changes the picture3.3.1.1 RIA - A Technology Shows its Age3.3.1.2 Immunoassay vs. PCR vs. Sequencing - A See-Saw Battle3.3.1.3 The Smart Shrinking Instrument - Serious Implications3.3.1.4 Research Funding and Capital Expense - Instrument Pooling3.3.1.5 Multiplex vs. POC - A Tradeoff Analysis3.3.2 Reagents and Kits - Genetics changes the picture3.3.2.1 Bigger Test Menus a Boon for Kit Market3.3.2.2 Physician Office Labs - A New Frontier3.3.3 Rapid and POCT to Threaten Instrument Markets3.3.4 OTC and DTC - Huge Market Potential3.3.5 Economies of Scale. Going Away?3.3.6 Lower Barriers to Entry for Instruments/Analyzers3.3.7 Miniaturization and Technology Drive Acquisition

Story continues

4 Market Trends4.1 Factors Driving Growth4.1.1 Diagnostic Factors4.1.2 Changing Technologies Spur Early Instrument Retirement4.1.3 Consumer Channels Open Wider4.1.4 Immunity Technology Comes of Age4.2 Factors Limiting Growth4.2.1 Increased Competition Lowers Price4.2.2 Threat from PCR Based Instruments4.2.3 Lower Barriers to Entry4.2.4 Wellness has a downside4.3 Immunoassay Instrumentation4.3.1 Instrumentation Tenacity4.3.2 Declining Cost of Instruments Changes Industry Structure4.3.3 Listing of Instrument Specifications4.3.4 Immunoassay - CRISPR Diagnostics

5 Immunoassay Recent Developments5.1 Recent Developments - Importance and How to Use This Section5.1.1 Importance of These Developments5.1.2 How to Use This Section5.2 FDA Grants EUA to Xtrava Health COVID Point-of-Care Antigen Test5.3 Alamar Biosciences Raises $80M for Immuno-Sandwich Assay Platform5.4 FDA grants breakthrough device to multiplex immunoassay5.5 Quidel, Beckman Settle Cardiac Immunoassay Dispute5.6 BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership5.7 BioMerieux Gets CE Mark for Three Dengue Immunoassays5.8 COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing5.9 Roche Diagnostics Expanding Testing Portfolio in 20215.10 PerkinElmer Long-Term Outlook5.11 Quidel Updates Outlook for C19 Testing5.12 Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza5.13 Becton Dickinson and NAT Diagnostics Acquisition5.14 New test diagnoses Lyme disease within 15 minutes5.15 Multiplexed Immunoassay System Differentiates Malaria Species5.16 ERBA Mannheim Unveils Next-Generation Nexus unit5.17 Uman Diagnostics And Bio-Techne Announce Agreement For Neurofilament Light Assay5.18 Software reduces variability in ELISA biomarker tests5.19 Arrayit Corporation Allergy Testing Network Doubles

6 Profiles of Key Companies6.1 Abbott Diagnostics6.2 Abcam6.3 Arlington Scientific6.4 Arrayit Corporation6.5 Autobio Diagnostics6.6 Awareness Technology6.7 Beckman Coulter Diagnostics6.8 Becton, Dickinson and Company6.9 Biocartis6.10 Biomatik6.11 bioMerieux Diagnostics6.12 Bioneer Corporation6.13 Bio-Rad Laboratories, Inc.6.14 BioTek Instruments6.15 Boditech Med, Inc6.16 Boster Biological Technology6.17 Diamedix (Erba Diagnostics)6.18 Diasorin S.p.A.6.19 Dynex Technologies6.20 Enzo Biochem6.21 Eurofins Scientific6.22 FUJIFILM Wako Diagnostics6.23 Fujirebio6.24 Gold Standard Diagnostics6.25 Grifols6.26 Hycor Biomedical6.27 Immunodiagnostic Systems (IDS)6.28 Immunodiagnostik AG6.29 Inova Diagnostics6.30 JR Biomedical6.31 Luminex Corp6.32 Maxim Biomedical6.33 Mbio Diagnostics6.34 Meso Scale Discovery6.35 Millipore Sigma6.36 Mindray6.37 Molecular Devices6.38 MP Biomedical6.39 MyCartis6.40 Operon6.41 Ortho Clinical Diagnostics6.42 Perkin Elmer6.43 Qiagen Gmbh6.44 Quidel6.45 R&D Systems6.46 Randox Toxicology6.47 Roche Molecular Diagnostics6.48 SD Biosensor6.49 Serametrix6.50 Siemens Healthineers6.51 Sysmex6.52 Tecan6.53 Thermo Fisher Scientific Inc.6.54 TOSOH Bioscience6.55 Veredus Laboratories6.56 Vircell6.57 YD Diagnostics6.58 Zhejiang Orient Gene Biotech

7 The Global Market7.1 Global Market by Country7.2 Global Market by Application7.3 Global Market by Technology7.4 Global Market by Product7.5 Global Market by User

8 Global Market by Application8.1 Endocrinology Applications8.2 Immune Applications8.3 Oncology Applications8.4 Infectious Disease Applications8.5 Cardiology Applications8.6 Other Applications

9 Immunoassay by Technology9.1 Enzyme9.2 Fluorescence9.3 Chemiluminescence9.4 Nucleic Acid9.5 Rapid/POC9.6 Other Technology

10 Immunoassay by Product10.1 Instrument10.2 Reagents10.3 Services

11 Immunoassay by User11.1 Hospital11.2 Outpatient Lab11.3 POC/Other

12 Vision of the Future of Immunoassay

13 Appendices13.1 United States Medicare System: 2021 laboratory Fees Schedule

For more information about this report visit https://www.researchandmarkets.com/r/wnx0xr

Media Contact:

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

Cision

View original content:https://www.prnewswire.com/news-releases/global-immunoassay-market-strategies-trends-forecasts-2022-2027-the-genetic-blizzard-and-the-move-to-point-of-care-drive-dramatic-change-for-traditional-immunoassay-technology-301591725.html

SOURCE Research and Markets

View post:
Global Immunoassay Market Strategies, Trends, Forecasts 2022-2027: The Genetic Blizzard and the Move to Point of Care Drive Dramatic Change for...

Insights on the Genetic Testing Global Market to 2027 – by Type, Technology, Application and Region – Ben – Benzinga

DUBLIN, July 22, 2022 /PRNewswire/ -- The "Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global genetic testing market reached a value of US$ 14.36 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 26.39 Billion by 2027, exhibiting a CAGR of 10.67% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Genetic testing, or deoxyribonucleic acid (DNA) testing, refers to a medical technique that identifies changes in the chromosome structure or DNA sequence. It includes the collection and analysis of individual blood samples for examining the genetic condition and the chances of developing or passing various inherited disorders in laboratory settings.

Genetic testing assists in providing accurate results regarding gene mutation, eliminating the need for unnecessary checkups, and making informed decisions to manage health. At present, genetic testing is commercially available in varying types, such as carrier, diagnostic, predictive, presymptomatic and prenatal testing.

The increasing prevalence of genetic and chronic disorders across the growth represents the key factor driving the genetic testing market growth. This is further supported by the implementation of numerous favorable initiatives undertaken by the government bodies and non-governmental organizations (NGOs) for sensitizing masses regarding genetic testing. In line with this, the extensive utilization of genetic testing in pharmacogenomics, or drug-gene testing for examining the response of the body against certain medicines after its interaction with inherited genes, is contributing as another growth-inducing factor.

Additionally, the sudden outbreak of coronavirus disease (COVID-19) pandemic has led to the widespread adoption of virtual testing and the home testing kits for sample collection purposes, which, in turn, is contributing to the market growth. The tremendous technological advancements in genetic testing techniques along with the introduction of DTC-GT (Direct-to-consumer genetic testing) kits are further propelling the market growth. Other factors, such as rising investments in the research and development (R&D) activities in the field of medical science, along with the strategic collaboration amongst top players for launching advanced personalized genetic testing kits, are creating a positive outlook for the market.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction4.1 Overview4.2 Key Industry Trends

5 Global Genetic Testing Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast

6 Market Breakup by Type6.1 Predictive and Presymptomatic Testing6.1.1 Market Trends6.1.2 Market Forecast6.2 Carrier Testing6.2.1 Market Trends6.2.2 Market Forecast6.3 Prenatal and Newborn Testing6.3.1 Market Trends6.3.2 Market Forecast6.4 Diagnostic Testing6.4.1 Market Trends6.4.2 Market Forecast6.5 Pharmacogenomic Testing6.5.1 Market Trends6.5.2 Market Forecast6.6 Others6.6.1 Market Trends6.6.2 Market Forecast

7 Market Breakup by Technology7.1 Cytogenetic Testing and Chromosome Analysis7.1.1 Market Trends7.1.2 Market Forecast7.2 Biochemical Testing7.2.1 Market Trends7.2.2 Market Forecast7.3 Molecular Testing7.3.1 Market Trends7.3.2 Key Segments7.3.2.1 DNA Sequencing7.3.2.1 Others7.3.3 Market Forecast

8 Market Breakup by Application8.1 Cancer Diagnosis8.1.1 Market Trends8.1.2 Market Forecast8.2 Genetic Disease Diagnosis8.2.1 Market Trends8.2.2 Market Forecast8.3 Cardiovascular Disease Diagnosis8.3.1 Market Trends8.3.2 Market Forecast8.4 Others8.4.1 Market Trends8.4.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 23andme Inc.14.3.1.1 Company Overview14.3.1.2 Product Portfolio14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)14.3.2.1 Company Overview14.3.2.2 Product Portfolio14.3.3 Bio-RAD Laboratories Inc.14.3.3.1 Company Overview14.3.3.2 Product Portfolio14.3.3.3 Financials14.3.3.4 SWOT Analysis14.3.4 Cepheid (Danaher Corporation)14.3.4.1 Company Overview14.3.4.2 Product Portfolio14.3.4.3 SWOT Analysis14.3.5 Eurofins Scientific14.3.5.1 Company Overview14.3.5.2 Product Portfolio14.3.5.3 Financials14.3.5.4 SWOT Analysis14.3.6 Illumina Inc.14.3.6.1 Company Overview14.3.6.2 Product Portfolio14.3.6.3 Financials14.3.6.4 SWOT Analysis14.3.7 Invitae Corporation14.3.7.1 Company Overview14.3.7.2 Product Portfolio14.3.7.3 Financials14.3.8 Luminex Corporation (DiaSorin)14.3.8.1 Company Overview14.3.8.2 Product Portfolio14.3.8.3 SWOT Analysis14.3.9 Myriad Genetics Inc.14.3.9.1 Company Overview14.3.9.2 Product Portfolio14.3.9.3 Financials14.3.9.4 SWOT Analysis14.3.10 QIAGEN14.3.10.1 Company Overview14.3.10.2 Product Portfolio14.3.10.3 Financials14.3.10.4 SWOT Analysis14.3.11 Quest Diagnostics14.3.11.1 Company Overview14.3.11.2 Product Portfolio14.3.11.3 Financials14.3.11.4 SWOT Analysis14.3.12 Thermo Fisher Scientific14.3.12.1 Company Overview14.3.12.2 Product Portfolio14.3.12.3 Financials14.3.12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/te1d65

Media Contact:

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Original post:
Insights on the Genetic Testing Global Market to 2027 - by Type, Technology, Application and Region - Ben - Benzinga

Non-random genetic alterations in the cyanobacterium Nostoc sp. exposed to space conditions | Scientific Reports – Nature.com

Schulze-Makuch, D., & Irwin, L.N. Astrobiological potential of planetary bodies within the solar system. Life in the Universe: Springer; 2018. pp. 203228.

Cockell, C. S. et al. Habitability: A review. Astrobiology 16(1), 89117 (2016).

ADS Article Google Scholar

Sancho, L. G. et al. Lichens survive in space: results from the 2005 LICHENS experiment. Astrobiology 7(3), 443454 (2007).

ADS Article Google Scholar

de La Torre, R. et al. Survival of lichens and bacteria exposed to outer space conditionsresults of the Lithopanspermia experiments. Icarus 208(2), 735748 (2010).

ADS Article Google Scholar

Rabbow, E. et al. The astrobiological mission EXPOSE-R on board of the International Space Station. Int. J. Astrobiol. 14(1), 316 (2015).

ADS Article Google Scholar

Potts, M. Nostoc 465504 (Springer, 2000).

Google Scholar

De Vera, J.-P. et al. Limits of life and the habitability of Mars: The ESA space experiment BIOMEX on the ISS. Astrobiology 19(2), 145157 (2019).

ADS Article Google Scholar

Gawad, C., Koh, W. & Quake, S. R. Single-cell genome sequencing: Current state of the science. Nat. Rev. Genet. 17(3), 175188 (2016).

CAS Article Google Scholar

Low, A. J., Koziol, A. G., Manninger, P. A., Blais, B. & Carrillo, C. D. ConFindr: Rapid detection of intraspecies and cross-species contamination in bacterial whole-genome sequence data. PeerJ 7, e6995 (2019).

Article Google Scholar

Liu, Y. & Walther-Antonio, M. Microfluidics: A new tool for microbial single cell analyses in human microbiome studies. Biomicrofluidics 11(6), 061501 (2017).

Article Google Scholar

Liu, Y. et al. The development of an effective bacterial single-cell lysis method suitable for whole genome amplification in microfluidic platforms. Micromachines. 9(8), 367 (2018).

Article Google Scholar

Liu, Y., Yao, J. & Walther-Antonio, M. Whole genome amplification of single epithelial cells dissociated from snap-frozen tissue samples in microfluidic platform. Biomicrofluidics 13(3), 034109 (2019).

Article Google Scholar

Liu, Y., Jeraldo, P., Jang, J., Eckloff, B., Jen, J., & Walther-Antonio, M. Bacterial single cell whole transcriptome amplification in microfluidic platform shows putative gene expression heterogeneity. Anal. Chem. (2019).

Liu, Y. et al. Whole genome sequencing of cyanobacterium Nostoc sp CCCryo 23106 using microfluidic single cell technology. Iscience. 25(5), 4291 (2022).

Google Scholar

https://sourceforge.net/projects/bbmap/. BBMap (2019).

Li, D., Liu, C.-M., Luo, R., Sadakane, K. & Lam, T.-W. MEGAHIT: An ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics 31(10), 16741676 (2015).

CAS Article Google Scholar

Laczny, C. C. et al. BusyBee Web: Metagenomic data analysis by bootstrapped supervised binning and annotation. Nucleic Acids Res. 45(W1), W171W179 (2017).

CAS Article Google Scholar

Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P. & Tyson, G. W. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 25(7), 10431055 (2015).

CAS Article Google Scholar

Parks, D. H. et al. Recovery of nearly 8000 metagenome-assembled genomes substantially expands the tree of life. Nat. Microbiol. 2(11), 1533 (2017).

CAS Article Google Scholar

Parks, D.H., Chuvochina, M., Waite, D.W., Rinke, C., Skarshewski, A., & Chaumeil, P.-A., et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat. Biotechnol. (2018).

Davis, J. J. et al. The PATRIC bioinformatics resource center: Expanding data and analysis capabilities. Nucleic Acids Res. 48(D1), D606D612 (2020).

CAS PubMed Google Scholar

McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., & DePristo, M.A. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. (2010).

Ruden, D. M. et al. Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program. SnpSift. Front. Genet. 3, 35 (2012).

PubMed Google Scholar

Yang, Z. & Bielawski, J. P. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15(12), 496503 (2000).

CAS Article Google Scholar

Kllberg, M. et al. Template-based protein structure modeling using the RaptorX web server. Nat. Protoc. 7(8), 1511 (2012).

Article Google Scholar

Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 1.8 (2015).

Pullerits, K. et al. Impact of UV irradiation at full scale on bacterial communities in drinking water. NPJ Clean Water. 3(1), 110 (2020).

Article Google Scholar

Golden, S. S. Light-responsive gene expression in cyanobacteria. J. Bacteriol. 177(7), 1651 (1995).

CAS Article Google Scholar

Dachev, T. P. et al. Overview of the ISS radiation environment observed during the ESA EXPOSE-R2 mission in 20142016. Space Weather 15(11), 14751489 (2017).

ADS Article Google Scholar

Sinha, R. P., Klisch, M., Helbling, E. W. & Hder, D.-P. Induction of mycosporine-like amino acids (MAAs) in cyanobacteria by solar ultraviolet-B radiation. J. Photochem. Photobiol. B 60(23), 129135 (2001).

CAS Article Google Scholar

Tamaru, Y., Takani, Y., Yoshida, T. & Sakamoto, T. Crucial role of extracellular polysaccharides in desiccation and freezing tolerance in the terrestrial cyanobacterium Nostoc commune. Appl. Environ. Microbiol. 71(11), 73277333 (2005).

ADS CAS Article Google Scholar

Guilhabert, M. R. & Kirkpatrick, B. C. Identification of Xylella fastidiosa antivirulence genes: hemagglutinin adhesins contribute to X fastidiosa biofilm maturation and colonization and attenuate virulence. Mol. Plant Microb. Interact. 18(8), 856868 (2005).

CAS Article Google Scholar

Nixon, R. A. & Sihag, R. K. Neurofilament phosphorylation: A new look at regulation and function. Trends Neurosci. 14(11), 501506 (1991).

CAS Article Google Scholar

Rabbow, E. et al. EXPOSE-R2: The astrobiological ESA mission on board of the International Space Station. Front. Microbiol. 8, 1533 (2017).

Article Google Scholar

Klementiev, K. E. et al. Radioprotective role of cyanobacterial phycobilisomes. Biochim. Biophys. Acta 2, 121128 (1860).

Google Scholar

Mosca, C. et al. Revival of anhydrobiotic cyanobacterium biofilms exposed to space vacuum and prolonged dryness: implications for future missions beyond low Earth orbit. Astrobiology 21(5), 541550 (2021).

ADS CAS Article Google Scholar

Kawaguchi, Y. et al. DNA damage and survival time course of deinococcal cell pellets during 3 years of exposure to outer space. Front. Microbiol. 11, 2050 (2020).

Article Google Scholar

Gladyshev, E. & Meselson, M. Extreme resistance of bdelloid rotifers to ionizing radiation. Proc. Natl. Acad. Sci. 105(13), 51395144 (2008).

ADS CAS Article Google Scholar

Zhu, Q., Niu, Y., Gundry, M. & Zong, C. Single-cell damagenome profiling unveils vulnerable genes and functional pathways in human genome toward DNA damage. Sci. Adv. 7(27), 3329 (2021).

ADS Article Google Scholar

Beaven, G. H., Holiday, E. R., Johnson, E. A., Ellis, B. & Petrow, V. The chemistry of anti-pernicious anaemia factors: Part VI: The mode of combination of component alpha in vitamin B12. J. Pharm. Pharmacol. 2(12), 944955 (1950).

CAS PubMed Google Scholar

Sinha, R., Kumar, H. D., Kumar, A. & Hder, D. Effects of UV-B irradiation on growth, survival, pigmentation and nitrogen metabolism enzymes in cyanobacteria. Acta Protozool. 34, 187 (1995).

CAS Google Scholar

Lynch, M. et al. Genetic drift, selection and the evolution of the mutation rate. Nat. Rev. Genet. 17(11), 704714 (2016).

CAS Article Google Scholar

Aleshkin, G. I., Kadzhaev, K. V. & Markov, A. P. High and low UV-dose responses in SOS-induction of the precise excision of transposons tn1, Tn5 and Tn10 in Escherichia coli. Mutat. Res. 401(12), 179191 (1998).

CAS Article Google Scholar

Zhu, Y., Neeman, T., Yap, V. B. & Huttley, G. A. Statistical methods for identifying sequence motifs affecting point mutations. Genetics 205(2), 843856 (2017).

CAS Article Google Scholar

Knight, R. D., Freeland, S. J. & Landweber, L. F. A simple model based on mutation and selection explains trends in codon and amino-acid usage and GC composition within and across genomes. Genome Biol. 2(4), 10 (2001).

Article Google Scholar

Continued here:
Non-random genetic alterations in the cyanobacterium Nostoc sp. exposed to space conditions | Scientific Reports - Nature.com

Finding the Right Memory Strategy to Slow Cognitive Decline – Neuroscience News

Summary: Study compares two forms of cognitive training used to help those with mild cognitive impairment to improve memory and learning.

Source: University of Michigan

Whats the best way to improve your memory as you age? Turns out, it depends, a new study suggests. But your fourth-grade math teacher may have been onto something with that phrase to help you remember how to work out a complicated problem: Please Excuse My Dear Aunt Sally.

A new study led by researchers from the University of Michigan and Penn State College of Medicinecompared two approaches for people with an early form of memory loss.

The two are mnemonic strategy training, which aims to connect what someone is trying to remember to something else like a word, phrase or song (such as the Dear Aunt Sally mnemonic), and spaced retrieval training, which gradually increases the amount of time between tests of remembering something.

People with mild cognitive impairment, which can but does not always lead to a later Alzheimers disease diagnosis, were better able to remember information when using one of these cognitive training approaches. However, the data, and brain scans that revealed which areas of the brain were more active, showed each activity works differently.

Our research shows that we can help people with mild cognitive impairment improve the amount of information they learn and remember; however, different cognitive training approaches engage the brain in distinct ways, said lead and corresponding authorBenjamin Hampstead, Ph.D. Hampstead is a professor of psychiatry at Michigan Medicine and the VA Ann Arbor Healthcare System.

He directs theResearch Program on Cognition and Neuromodulation Based Interventionsand leads the Clinical Core and co-leads the Neuroimaging Core at the federally fundedMichigan Alzheimers Disease Research Center.

Mnemonic strategy training increased activity in brain areas often affected by Alzheimers disease, which likely explains why this training approach helped participants remember more information and for longer, Hampstead said.

In contrast, those completing rehearsal-based training showed reduced brain activity, which suggests they were processing the information more efficiently.

Hampstead and his team worked with Krish Sathian, MBBS, Ph.D., professor and chair of Penn States Department of Neurology and director of Penn State Neuroscience Institute. Sathian noted that cognitive training approaches are likely to become increasingly important in synergy with the new pharmacological treatments on the horizon for those with neurodegenerative disorders.

Moving forward, Hampstead said researchers and clinicians can use this type of information to help identify the best-fit non-pharmacologic treatments for their patients with memory impairment.

Additional authors include Anthony Y. Stringer, Ph.D. of Emory University, and U-M team members Alexandru D. Iordan, Ph.D. and Rob Ploutz-Snyder, Ph.D.

Author: Kara GavinSource: University of MichiganContact: Kara Gavin University of MichiganImage: The image is in the public domain

Original Research: Closed access.Towards rational use of cognitive training in those with mild cognitive impairment by Benjamin Hampstead et al. Alzheimers Disease & Dementia

Abstract

Towards rational use of cognitive training in those with mild cognitive impairment

The term cognitive training includes a range of techniques that hold potential for treating cognitive impairment caused by neurologic injury and disease.

Ourcentral premiseis that these techniques differ in their mechanisms of action and therefore engage distinct brain regions (or neural networks).

We support this premise using data from a single-blind randomized-controlled trial in which patients with mild cognitive impairment were randomized to either mnemonic strategy training (MST) or spaced retrieval training (SRT) as they learned ecologically relevant object-location associations.

Both training approaches were highly effective in the short term, but MST demonstrated a clear advantage after days to weeks. MST also increased activation in and functional connectivity between frontal, temporal, and parietal regions as well as the hippocampus.

In contrast, patterns of reduced activation and functional connectivity were evident following SRT. These findings support the rational development of cognitive training techniques.

View original post here:
Finding the Right Memory Strategy to Slow Cognitive Decline - Neuroscience News

Making a Memory Positive or Negative – Neuroscience News

Summary: Researchers discovered a specific neurotransmitter that helps assign either positive or negative emotions to memories.

Source: Salk Institute

Researchers at the Salk Institute and colleagues have discovered the molecule in the brain responsible for associating good or bad feelings with a memory.

Their discovery, published inNatureon July 20, 2022, paves the way for a better understanding of why some people are more likely to retain negative emotions than positive onesas can occur with anxiety, depression or post-traumatic stress disorder (PTSD).

Weve basically gotten a handle on the fundamental biological process of how you can remember if something is good or bad, says senior authorKay Tye, a professor in Salks Systems Neurobiology Laboratory and a Howard Hughes Medical Institute Investigator. This is something thats core to our experience of life, and the notion that it can boil down to a single molecule is incredibly exciting.

For a human or animal to learn whether to avoid, or seek out, a particular experience again in the future, their brain must associate a positive or negative feeling, or valence with that stimulus. The brains ability to link these feelings with a memory is called valence assignment.

In 2016, Tye discovered that a group of neurons in the brains basolateral amygdala (BLA) helps assign valence when mice are learning. One set of BLA neurons was activated with positive valence, as the animals learned to associate a tone with a sweet taste. A separate set of BLA neurons was activated with negative valence, as the animals learned to associate a different tone with a bitter taste.

We found these two pathwaysanalogous to railroad tracksthat were leading to positive and negative valence, but we still didnt know what signal was acting as the switch operator to direct which track should be used at any given time, says Tye, holder of the Wylie Vale Chair.

In the new study, the researchers homed in on the importance of the signaling molecule neurotensin to these BLA neurons. They already knew that neurotensin is a neuropeptide produced by the cells associated with valence processing, but so are a few other neurotransmitters. So, they used CRISPR gene editing approaches to selectively remove the gene for neurotensin from the cellsthe first time that CRISPR has been used to isolate specific neurotransmitter function.

Without neurotensin signaling in the BLA, mice could no longer assign positive valence and didnt learn to associate the first tone with a positive stimulus. Interestingly, the absence of neurotensin did not block negative valence. The animals instead became even better at negative valence, having a stronger association between the second tone and a negative stimulus.

The findings suggest that the brains default state is to have a bias toward fearthe neurons associated with negative valence are activated until neurotensin is released, switching on the neurons associated with positive valence. From an evolutionary perspective, Tye says, this makes sense because it helps people avoid potentially dangerous situationsand it probably resonates with people who tend to find the worst in a situation.

In further experiments, Tye and her team showed that high levels of neurotensin promoted reward learning and dampened negative valence, further supporting the idea that neurotensin is responsible for positive valence.

We can actually manipulate this switch to turn on positive or negative learning, says co-first author Hao Li, a postdoctoral fellow in the Tye Lab. Ultimately, wed like to try to identify novel therapeutic targets for this pathway.

The researchers still have questions about whether levels of neurotensin can be modulated in peoples brains to treat anxiety or PTSD. They are also planning future studies to probe what other brain pathways and molecules are responsible for triggering the release of neurotensin.

Other authors of the paper were Matilde Borio, Mackenzie Lemieux, Austin Coley, Avraham Libster, Aneesh Bal, Caroline Jia, Jasmin Revanna, Kanha Batra, Kyle Fischer, Laurel Keyes, Nancy Padilla-Coreano and Romy Wichmann of Salk; Praneeth Namburi, Jacob Olson, Anna Beyeler, Gwendolyn Calhoon, Natsuko Hitora-Imamura, Ada Felix-Ortiz, Vernica de la Fuente, Vanessa Barth, Hunter King, Ehsan Izadmehr, Cody Siciliano and Ila Fiete of MIT; Xin Jin, Sourav Choudhury, Xi Shi and Feng Zhang of the Broad Institute of MIT and Harvard; Huan Wang and Yulong Li of Peking University; and Kenneth McCullough and Kerry Ressler of Harvard Medical School.

Funding: The work was supported by the JPB Foundation, PIIF, PNDRF, JFDP, Alfred P. Sloan Foundation, New York Stem Cell Foundation, Klingenstein Foundation, McKnight Foundation, Clayton Foundation, National Institutes of Health (R01-MH102441, RF1-AG047661, DP2-DK102256, DP1-AT009925, F32 MH115446-01 and K99 DA055111), the Brain and Behavior Research Foundation, MEXT (15K21744, 17H06043), the Uehara Memorial Foundation, Singleton, Leventhal and Whitaker fellowships, a fellowship from the Swiss National Science Foundation and a Fulbright scholarship.

Author: Press OfficeSource: Salk InstituteContact: Press Office Salk InstituteImage: The image is credited to Salk Institute

Original Research: Closed access.Neurotensin orchestrates valence assignment in the amygdala by Kay Tye et al. Nature

Abstract

Neurotensin orchestrates valence assignment in the amygdala

The ability to associate temporally segregated information and assign positive or negative valence to environmental cues is paramount for survival. Studies have shown that different projections from the basolateral amygdala (BLA) are potentiated following reward or punishment learning.

However, we do not yet understand how valence-specific information is routed to the BLA neurons with the appropriate downstream projections, nor do we understand how to reconcile the sub-second timescales of synaptic plasticitywith the longer timescales separating the predictive cues from their outcomes.

Here we demonstrate that neurotensin (NT)-expressing neurons in the paraventricular nucleus of the thalamus (PVT) projecting to the BLA (PVT-BLA:NT) mediate valence assignment by exerting NT concentration-dependent modulation in BLA during associative learning.

We found that optogenetic activation of the PVT-BLA:NT projection promotes reward learning, whereas PVT-BLA projection-specific knockout of the NT gene (Nts) augments punishment learning. Using genetically encoded calcium and NT sensors, we further revealed that both calcium dynamics within the PVT-BLA:NT projection and NT concentrations in the BLA are enhanced after reward learning and reduced after punishment learning.

Finally, we showed that CRISPR-mediated knockout of theNtsgene in the PVT-BLA pathway blunts BLA neural dynamics and attenuates the preference for active behavioural strategies to reward and punishment predictive cues. In sum, we have identified NT as a neuropeptide that signals valence in the BLA, and showed that NT is a critical neuromodulator that orchestrates positive and negative valence assignment in amygdala neurons by extending valence-specific plasticity to behaviourally relevant timescales.

Link:
Making a Memory Positive or Negative - Neuroscience News

Self-Reflection Linked to Improved Late-Life Cognition and Brain Health – Neuroscience News

Summary: A persons ability to self-reflect is associated with cognition and glucose metabolism later in life, a new study finds. Those who engage in more self-reflection had improved cognition, better overall brain health, and increased glucose metabolism later in life.

Source: UCL

Self-reflection is positively associated with cognition late in life as well as glucose metabolism, a marker of brain health, finds a new study led by UCL researchers.

The authors of the new study, published inNeurology, say thatolder adultswho engage inself-reflectionmay have a reduced risk ofdementia.

Lead author, Ph.D. student Harriet Demnitz-King (UCL Psychiatry), says that there is a growing body of evidence finding that positive psychological factors, such as purpose in life and conscientiousness, may reduce the risk of dementia.

Finding further ways to reduce the risk of dementia is an urgent priority, so we hope that as self-reflection capabilities can be improved upon, it could be a useful tool in helping people to stay cognitively healthy as they age.

Anyone can engage in self-reflection and potentially increase how much they self-reflect, as it is not dependent onphysical healthor socioeconomic factors.

The study used cross-sectional data (rather than reporting results of the trial interventions) from two clinical trials, Age-Well and SCD-Well, that included a total of 259 participants with mean ages of 69 and 73. They answered questions about reflective pondering, measuring how often they think about and try to understand their thoughts and feelings.

The researchers found that people who engaged more in self-reflection had better cognition and improvedglucose metabolismas shown by brain imaging. The researchers did not find any association with amyloid deposition, the build-up of harmful brain proteins linked to Alzheimers disease.

Previous research has shown that self-reflection capabilities can be improved with a recently tested psychological intervention, and the researchers say that such a program might be useful for people at risk of dementia.

Harriet Demnitz-King explained that other studies have found that a self-reflective thinking style leads to a more adaptive stress response, with evidence even showing improvements ininflammatory responsesto stress and better cardiovascular health, so this may be how self-reflection could improve our resilience againstcognitive decline.

They caution that while their findings suggest that engagement in self-reflection helps to preserve cognition, they cannot rule out that it might instead be that people with better cognition are also better able to self-reflect, and suggest that more, longitudinal research is needed to determine the direction of causation.

Senior author Dr. Natalie Marchant (UCL Psychiatry) says that with no disease-modifying treatments yet available, it is important that we find ways to prevent dementia; by finding out which factors make dementia or cognitive decline more or less likely, we may be able to develop ways to target these factors and reduce dementia risk.

Self-reflection has also been associated with other benefits, such as recovery from depression and better cardiovascular health, so even if we cannot confirm exactly how it might impact cognitive decline, there is other evidence showing its overall benefits.

Previous studies by Dr. Marchant have found that repetitive negative thinking may increase the risk of Alzheimers disease, while mindfulness may help to improve cognition in older adults.

Dr. Richard Oakley, Associate Director of Research at Alzheimers Society, commented that in this study researchers showed for the first time that self-reflectionreflecting on your own thoughts, feelings and behaviorswas linked to better brain function in areas of thebrainknown to be affected by dementia.

While more research is needed to fully understand the implications of this finding, if self-reflection does seem to have a positive effect onbrain function, theres a chance one day we could reduce the risk of dementia with psychological treatments that help people build healthy thought patterns.

The number of people living with dementia in the UK is set to rise to 1.6 million by 2040the Government committing to double dementia research funding will ensure researchers can explore every way to reduce the risk.

Author: Chris LaneSource: UCLContact: Chris Lane UCLImage: The image is in the public domain

Original Research: Closed access.Association Between Self-Reflection, Cognition, and Brain Health in Cognitively Unimpaired Older Adults by Harriet Demnitz-King et al. Neurology

Abstract

Association Between Self-Reflection, Cognition, and Brain Health in Cognitively Unimpaired Older Adults

Background and Objectives:Self-reflection (the active evaluation of ones thoughts, feelings and behaviours) can confer protection against adverse health outcomes. Its impact on markers sensitive to Alzheimers disease (AD), however, is unknown. The primary objective of this cross-sectional study was to examine the association between self-reflection and AD-sensitive markers.

Methods:This study utilised baseline data from cognitively unimpaired older adults enrolled in the Age-Well clinical trial and older adults with subjective cognitive decline from the SCD-Well clinical trial. In both cohorts, self-reflection was measured via the reflective pondering subscale of the Rumination Response Scale, global cognition assessed via the Preclinical Alzheimers Cognitive Composite 5, and a modified late-life Lifestyle-for-Brain-Health (LIBRA) index computed to assess health and lifestyle factors.

In Age-Well, glucose metabolism and amyloid deposition were quantified in AD-sensitive grey matter regions via FDG- and AV45-PET scans, respectively. Associations between self-reflection and AD-sensitive markers (global cognition, glucose metabolism, and amyloid deposition) were assessed via unadjusted and adjusted regressions. Further, we explored whether associations were independent of health and lifestyle factors. To control for multiple comparisons in Age-Well, false discovery rate correctedp-values (pFDR) are reported.

Results:A total of 134 (mean age 69.3 3.8 years, 61.9% female) Age-Well and 125 (mean age 72.6 6.9 years, 65.6% female) SCD-Well participants were included. Across unadjusted and adjusted analyses self-reflection was positively associated with global cognition in both cohorts (Age-Well: adjusted-= 0.22, 95% confidence interval [CI] 0.05-0.40,pFDR= 0.041; SCD-Well: adjusted-= 0.18,95% CI 0.03-0.33,p= 0.023) and with glucose metabolism in Age-Well after adjustment for all covariates (adjusted-= 0.29, 95% CI 0.03-0.55,pFDR= 0.041). Associations remained following additional adjustment for LIBRA but did not survive FDR correction. Self-reflection was not associated with amyloid deposition (adjusted-= 0.13, 95% CI -0.07-0.34,pFDR= 0.189).

Discussion:Self-reflection was associated with better global cognition in two independent cohorts and with higher glucose metabolism after adjustment for covariates. There was weak evidence that relationships were independent from health and lifestyle behaviours. Longitudinal and experimental studies are warranted to elucidate whether self-reflection helps preserve cognition and glucose metabolism, or whether reduced capacity to self-reflect is a harbinger of cognitive decline and glucose hypometabolism.

Trial Registration:Age-Well:NCT02977819; SCD-Well:NCT03005652

More here:
Self-Reflection Linked to Improved Late-Life Cognition and Brain Health - Neuroscience News

Psychological Traits of Violent Extremism Investigated Using New Research Tool – Neuroscience News

Summary: The newly developed Extremist Archetypes Scale includes five dimensions of extremist archetypes.

Source: PLOS

Researchers have developed and validated a new tool known as the Extremist Archetypes Scale to help distinguish different psychological traits found among people engaged in violent extremism.

Milan Obaidi and Sara Skaar of the University of Oslo, Norway, and colleagues present the tool and validation results in the open-access journalPLOS ONEon July 20.

People who join violent extremist groups may differ widely in their motivations, knowledge, personalities, and other factors. However, research into violent extremism has often neglected this variation, limiting the scope and usefulness of such research. To help address this issue, Obaidi and colleagues built on earlier research to develop a new scale that captures heterogeneity among extremists.

Their new Extremist Archetypes Scale includes five dimensions of extremist archetypes: adventurer, fellow traveler, leader, drifter and misfit. An adventurer, for instance, may be drawn to extremism out of excitement and the prospect of being a hero, while a drifter may seek group belonging.

The researchers chose to treat archetypes as dimensions in order to allow for instances in which an extremist does not fall perfectly within a single archetype and to be able to capture a persons transition into an extremist archetype.

Next, the researchers conducted several analyses to help validate the Extremist Archetypes Scale. They tested associations between peoples scores on the scale and their scores on several well-established scales that evaluate personality traits, sociopolitical attitudes, ideologies, prejudice, and ethnic identification. In addition, they validated the scales applicability across diverse instances related to gender, political orientation, age, and ethnicity.

The validation analyses supported the predictive validity of the scaleincluding across political orientation and ethnicityas well as the idea that the archetypes consistently reflect different personality and behavioral profiles.

For instance, the adventurer archetype was associated with personality traits of extraversion and violent behavioral intentions, and the misfit was associated with narcissism, Machiavellianism, and psychopathy.

The researchers suggest that application of their scale in future research could help inform counter-extremism efforts. They also note that they focused on group-based extremism, but future research could examine archetypes of extremists who act alone.

The authors add: The current research developed the Extremist Archetypes Scale, whichmeasures different archetype dimensions that reflect different motivations for joining extremist groups and obtaining different roles within them.

Author: Hanna AbdallahSource: PLOSContact: Hanna Abdallah PLOSImage: The image is in the public domain

Original Research: Open access.Measuring extremist archetypes: Scale development and validation by Milan Obaidi et al. PLOS ONE

Abstract

Measuring extremist archetypes: Scale development and validation

Previous work has often disregarded the psychological heterogeneity of violent extremists. This research aimed to contribute to a more nuanced understanding of the psychological diversity of violent extremists.

Based on qualitative work, we developed and validated the Extremist Archetypes Scale, identifying five distinct archetype dimensions: adventurer, fellow traveler, leader, drifter and misfit.

Study 1 identified five dimensions among White majority members (N= 307), four of which were related to extremist violent intentions and which dissociated in terms of sociopolitical ideologies and intergroup attitudes.

Preregistered Study 2 (N= 308) confirmed the scales five-factor solution in another sample of White majority members, replicated relationships with violent intentions, and demonstrated the dimensions distinct personality correlates.

As in Study 1, the archetype dimensions had positive associations with extremist violent intentions and tapped onto different psychological profiles in terms of major personality traits. Study 3 (N= 317) replicated these results in a sample of Muslim minority members.

Measurement equivalence was established across gender, age, political orientation, and ethnicity (majority and minority).

Read more:
Psychological Traits of Violent Extremism Investigated Using New Research Tool - Neuroscience News

Neuroscience Says These 5 Simple Tricks Will Calm Your Anxiety Instantly – Inc.

Fortunately,we can point to simple techniques that neuroscience suggestswork effectively tomake people much less anxious--quicker than you think.

1. Listen to this specially designed song.

I'm putting this first because it's my favorite and I'm still shocked at how well it works.

A decade ago, British musicians teamed up with sound therapists to record a song called Weightlessnessthat stimulates specific neurological reactions: lower heart rate, lower blood pressure, and reduced levels of the stress hormone, cortisol.

"The song...contains a sustaining rhythm that starts at 60 beats per minute and gradually slows to around 50," explained Lyz Cooper, founder of the British Academy of Sound Therapy. "While listening, your heart rate gradually comes to match that beat."

It's just eight minutes long, andit works like a charm. I first tried it several years ago, and I've kept it bookmarked on my computer ever since. I'll embed a YouTube version at the end of this column.

2. Use the 4-7-8 breathing method.

Another very easy, almost too-good-to-be-true method that actually works. In short, by breathing in a very simple way, you can kick-start your parasympathetic nervous system, which causes the body to become calmer.

Repeat steps 3, 4 and 5 a total of three times. Bonus: If you're ever lying awake at night unable to sleep, the 4-7-8 method of breathing works wonders for that, too.

3. Get 45 minutes of vigorous exercise.

This one is fairly recent, and it comes from the International Journal of Environmental Research and Public Health. Researchers studied 66 college students during the pandemic, and concluded that negative thoughts and anxiety were appreciably less prevalent when participants exercised:

Choose whatever works for your ambition and schedule; I tend to recommend the 45 minute version, simply because if part of what is creating anxiety is concern about getting things done, adding a 2-hour habit to your day might be a bit self-defeating.

4. Get some nature.

We have all kinds of studies to point to here. Two of my colleagues on Inc.com have written pretty extensively about how taking an "awe walk" in nature can make people feel less anxious -- even one lasting just 15 minutes.

You don't even have to walk, necessarily; researchers found that simply commuting to work through "outdoor spaces that contain 'green' and/or 'blue' natural elements" (think trees, grass, and bodies of water) made people less anxious.

For that matter, researchers at the University of Hyogo in Japan say that simply putting small plants on workers' desks in an office "contributed to their psychological stress reduction regardless of their age or plants choice."

Bottom line, it's a lot harder to be anxious when you're surrounded by green and blue.

5. Save it for later.

This last trick is less about shutting off anxiety than it is about making it manageable. In short, make a note about the things that make you anxious -- even a literal, written note -- and then promise yourself that you'll set a block of time later in the day to be worried about them.

Seriously, pick a time and put it on your schedule: "From 2 p.m. to 2:20 p.m. is my "worry time." Any other time of day, I jot down my worries so I can feel anxious about them at the appropriate time."

"This strategy focuses on not postponing your worries," psychologist Dr. Regine Galanti explained to Time, "[instead] setting up a time where you can worry all you want. ... [I]t sets boundaries, so when a worry comes up at 9 a.m., you can say, 'Hey, not now, your time is coming.'"

Perhaps the best part about this trick? By whatever time you've set aside for worrying, you'll often find you're no longer worried.

Bonus:Train your brain

As I write in my free e-book Neuroscience: 13 Ways to Understand and Train Your Brain for Life, there's nothing more fascinating than the human brain, and the unexpected ways in which it works.

If it helps to get rid ofanxiety, that has to be at the top of the list.

Here's the embed of the 8-minute song, Weightlessness,that I promised above. I recommend watching it within this article rather than clicking out, otherwise your calming music might be jarringly interrupted by an ad.

The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.

Follow this link:
Neuroscience Says These 5 Simple Tricks Will Calm Your Anxiety Instantly - Inc.